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Abstract-Five distinct glycosaminoglycan fractions have been isolated from human 
brain of various age groups, by employing an improved fractionation procedure. Analysis 
of these fractions showed that human brain contains hyaluronic acid, chondroitin-4- 
sulphate, chondroitin-6-sulphate, dermatan sulphate, heparan sulphate and two un- 
identified low sulphated fractions. The pattern of variation of these compounds with age, 
indicates that they may be playing an important role in the process of myelination and 
brain maturation. 
STUDIES from several laboratories have established the presence of glycosaminoglycans 
(GAG) in the tissues of the central nervous system. But two important points still 
remain to be established: (i) the exact nature of GAG and (ii) the physiological role 
of these compounds in brain. 
There is general agreement on the occurrence of hyaluronic acid and chondroitin 
sulphates in the brain; but a complete characterization of these compounds has yet 
to be achieved. SZABO and ROBOZ-EINSTEIN (1962) isolated hyaluronic acid and 
chondroitin-4-sulphate from bovine brain, while CLAUSEN and HANSEN (1 963) 
demonstrated the presence of hyaluronic acid, dermatan sulphate and chondroitin-6- 
sulphate in human brain. On the other hand, MEYER, HOFFMAN, GRUMBACH and 
SAMPSON (1959) reported the presence of dermatan sulphate and heparan sulphate in 
the brain of a gargoyle patient; and hyaluronic acid and heparan sulphate in the brain 
of a child used as the normal control in this study. Earlier work from this laboratory 
on GAG of sheep brain (SINGH and BACHHAWAT, 1965) showed the presence of some 
minor components of GAG fractions, not fully characterized, along with hyaluronic 
acid, chondroitin-6-sulphate and chondroitin-4-sulphate. In the present investigation, 
an attempt has been made to get a profile of uronic acid-containing GAG in human 
brain, of various age groups, as completely as possible, employing improved tech- 
niques of isolation. 
Although the postulation of BRANTE (1958), as to the possible role of these com- 
pounds in the process of myelination has attracted the attention of many workers 
in this field, very little is known regarding the functional aspect. Earlier work from 
this laboratory (GUHA, NORTHOVER and BACHHAWAT, 1960; BALASUBRAMANIAN and 
BACHHAWAT, 1964; SINGH and BACHHAWAT, 1965) provided evidence of the im- 
portance of these compounds in the processes of myelination and brain maturation. 
Work of SZABO and ROBOZ-EINSTEIN (1962) also indicated that hyaluronic acid may 
be one of the building blocks of the myelin sheath. 
Abbreviations used: GAG, glycosaminoglycans; CPB, cetyl pyridinium bromide. 
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MATERIALS A N D  M E T H O D S  
Glucosamine, galactosamine, hyaluronic acid from human umbilical cord, bovine testicular 
hyaluronidase, yeast hexokinase type IV and ATP were obtained from Sigma Chemical Co., U.S.A. 
Chondroitin sulphate from bovine nasal septa and cetyl pyridinium bromide were purchased from 
Mann Research Laboratories, U.S.A. Sephadex G-25 and DEAE-Sephadex A-25 were supplied by 
Pharmacia, Upsala, Sweden. Chondroitin-6-sulphate, dermatan sulphate and heparan sulphate were 
gifts from Dr. A. DORFMAN of LaRabida University of Chicago-Institute, Chicago, U.S.A. Papain 
(crude) was a gift from Central Food Technological Research Institute, Mysore, India, whereas 
PronaseB was obtained from California Biochemicals Corp., U.S.A. Carbazole (British Drug 
House) was recrystallized from benzene. Other chemicals used were of analytical grade. 
Human brain of various age groups, viz., foetal, neonatal, child (1-year-old) and adult, were 
autopsy samples made available through the courtesy of the Pathology Department of this Institute. 
Care has been taken to eliminate specimens having any apparent neurological abnormality. Tissues 
were cleaned free from meninges and adhering blood vessels as far as possible and used as such or 
kept frozen at  -20" till required. 
Acetone drying, lipid extraction and GAG extraction. Tissues were acetone-dried by homogenizing 
them in 10 vol. of acetone in a Servall Omni-Mixer and lipids were extracted from the dried tissues by 
further homogenization in 19 vol. of chloroform-methanol (2: 1) and the residues after tiltration 
were used for the extraction of GAG. 
The dried lipid-free material was homogenized in 10 vol. of 0.1 M-acetate buffer, pH 5.0, and 
heated for 20 min in a boiling water bath. After cooling to room temperature, it was digested with 
papain (5 mg/g of tissue) at 60" for 24 hr in the presence of 0.005 M-cysteine (freshly prepared) and 
0005 M-EDTA. 
The papain digest was dialysed overnight and M-tris-HCI buffer, pH 7-6, was added to make it 
0 1  M, along with alcohol (0.001 M) and CaCl, (0.001 M) and further digested with Pronase-B (5 mg/g 
of tissue) for 48 hr a t  37" under a layer of petroleum ether (60-80). 
To the Pronase digest 2 N-NaOH was added to make it 0-1 N and stirred in the cold for 24 hr. It 
was then neutralized with 30% TCA and deproteinized by further addition of TCA (final concen- 
tration 5 %), centrifuged and dialysed overnight against running tap water. 
GAG were precipitated by CPB and fractionated into three fractions by differential extraction 
with increasing concentrations of NaCl according to the method of SCHILLER, SLOVER and DORPMAN 
(1961), and finally precipitated with alcohol (80%). 
Further fractionation by DEAE-Sephadex column chromatography. Each fraction obtained by the 
CPB procedure was subjected to DEAE-Sephadex A-25 column chromatography according to 
the method of SCHMIDT (1962) using the following eluants: (A) 0.5 M-NaCl; (B) 0 9  M-NaCI; (C) 
1-5 M-NaCI in 0.01 M-HCI; and (D) 2 0  M-NaC1 in 0.01 M-HCl. The fractionation pattern can be 
summarized as: 
Tissue extract 
Fractionation by the CPB procedure 
-1 
Fraction I11 
-1 
Fraction I Fraction I1 
i DEAE-Sephadex I chromatography DEAE-Sephadex chromatography 1 DEAE-Sephadex chromatography 
ALT. 
ND N D  111-SC ND 
A [ W /  A I F L  
I-SA I-SB ND ND N D  11-SB 11-SC N D  
(ND-Not detectable) 
In all the cases studied, five distinct fractions were obtained by adopting this procedure. 
Paper electrophoresis. Paper electrophoresis of the isolated fractions was carried out with lithium 
sulphate of 0.1 ionic strength as the electrolyte (FOSTER and PEARCE, 1961) and then stained with 
0.5 per cent alcian blue in 3 % acetic acid. 
Hyaluronidase digestion and estimation of chondroitin-6-sulphate. Various GAG fractions isolated 
from human brain of different age groups were separately digested with testicular hyaluronidase in 
0.1 M-acetate buffer, pH 5.0, for 16 hr at 37" and the amounts of hyaluronidase-resistant material as 
well as chondroitin-6-sulphate in these fractions were determined by gel filtration in Sephadex G-25 
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columns by the method of SCHMIDT and DMOCHOWSKI (1964) and by acylhexosamine assay procedure 
of MATHEW and INOWE (1961) respectively, as has been described earlier (SINGH and BACHHAWAT, 
1965). 
Constituent analysis. Uronic acid was determined by Dische's carbazole method (DISCHE, 1947) 
as modified by BITTER and MUIR (1962) using glucuronolactone as the standard. For the identification 
of dermatan sulphate, the carbazole reaction was carried out, with and without borate, since iduronic 
acid gives a very low colour yield without borate in the reaction mixture. 
For the analysis of hexosamines, the various GAG fractions were hydrolysed with 6 N-HCI at  
100" in sealed tubes for 8 hr and the hydrolysates dried over fused CaCI, and NaOH pellets in a 
vacuum desiccator. The hexosamines were assayed by the method of GATT and BERMAN (1966) 
employing glucosamine and galactosamine as the respective standards and the total hexosamine was 
expressed as the sum of glucosamine and galactosamine after estimating them separately. 
For the separation of glucosamine and galactosamine, a portion of the aminosugar was phos- 
phorylated with yeast hexokinase and glucosamine-6-phosphate was separated from galactosamine 
by Dowex-l-acetate column chromatography. Galactosamine was not held up in this column and as 
such appeared in the breakthrough and the aqueous washings while glucosamine-6-phosphate was 
eluted with 0.025 M-acetic acid. 
The hexosamines were further identified by descending paper chromatography according to the 
method of MUKHERJI and SRIRAM (1964). After drying the paper, the reducing sugar spots were 
identified by staining with alkaline silver nitrate (TREVELYAN, PROCTOR and HARRISON, 1950). 
The total sulphate content of the isolated GAG fractions was determined by BaCI,-gelatin method 
of DODGSON and PRICX (1962). 
N-sulphate residues (or to be more precise, non-acylated hexosamines) in the isolated GAG 
fractions were determined by the method of LAGUNOFF and WARREN (1962) using glucosamine as the 
standard. 
RESULTS 
Variation of GAG fractions with age in human brain. The levels of three GAG 
fractions (obtained by the CPB procedure) in human brain of four different age 
groups, are presented in Table 1. GAG are present at the foetal stage and at birth, 
TABLE MAT LEVELS OF VARIOUS GAG FRACTIONS IN HUMAN BRAIN OF 
VARIOUS AGE GROUPS 
mg uronic acid/g dry defatted tissue 
Age group Fraction I Fraction I1 Fraction I11 Total 1/11 
Foetal 0.782 0.495 0.026 1.303 1-58 
Neonatal 1.66 0.82 0.08 1 2.561 2-05 
Child 1.27 1-31 0.04 2.62 0.89 
Adult 0.61 2 0.798 0.075 1-485 0.78 
(1-y-old) 
A large batch isolation was carried out using the dried lipid-free material. 
Extraction of GAG was done by digestion with papain, pronase and alkali. 
Fractionation was performed by the CPB method. 
the amount is quite high. It slightly increases at the age of 1 year and returns almost 
to the foetal level at the adult stage. During the pre-myelination stage (foetal and 
neonatal) the values of Fraction I are much higher than those of Fraction 11. But as 
the brain develops, the relative proportion of these two fractions changes. During the 
peak period of myelination (l-year-old) the ratio of 1/11 is 0.89 and at the adult stage 
it is 0.78. These findings agree well with our earlier findings in the developing rat 
brain (SINGH and BACHHAWAT, 1965). 
The results of further subfractionation of the CPB fractions by DEAE-Sephadex 
column chromatography show (Table 2) that I-SA is highest in the neonatal, I-SB 
and II-SB, in the child and II-SC in the adult. In all the cases, I-SA is higher than 
I-SB and the ratio of I-SA/I-SB is lowest in the foetal (1-25) and highest in the neonatal 
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TABLE 2.-FURTHER FRACTIONATION BY DEAE-SEPHADEX OF GAG FRACTIONS OF HUMAN BRAIN 
OF VARIOUS AGE GROUPS 
I-SA 11-SB 
1-SB 11-sc 
mg uronic acid/g dry defatted tissue 
- 
I-SB 11-SB 11-sc Age group I-SA 
~~ 
Foetal 0.488 0.294 Not done Not done 1.25 - 
Neonatal 1,495 0.165 0 205 0.615 9.00 0.33 
Child 0.94 0.33 0.226 1.084 2.86 0.2 1 
Adult 0.528 0.084 0,296 0.502 6.25 0.59 
The subfractionation of the GAG fractions (obtained by the CPB procedure) was carried out 
(9.09), age group. In general 11-SC is higher than 11-SB and the ratio of 11-SB/II-SC 
is highest in the adult. 
Hyaluronidase digestion of various GAG fractions of human brain of different age 
groups. Table 3 presents the results of testicular hyaluronidase digestion and chon- 
droitin-Qsulphate estimation of some of the GAG fractions. 11-SB contains con- 
siderable amounts of hyaluronidase-resistant material (3WO per cent) while 11-SC is 
almost completely digested. In all the cases I-SB was found to contain some un- 
digestible material (7-18 per cent). 
on DEAE-Sephadex columns by stepwise elution as described in the text. 
TABLE 3.-TESTICULAR HYALURONIDASE DIGESTION OF THE VARIOUS GAG FRACTIONS 
OBTAINED FROM HUMAN BRAIN OF DIFFERENT AGE GROUPS 
% Chondroitin-4- 
Age group and % Hyaluronidase % Chondroitin-6- sulphate 
fractions undigestible sulphate* (by difference) 
Foetal 
Neonatal 
I-SB 
I-SB 
11-SB 
11-sc 
I-SB 
11-SB 
11-sc 
I-SB 
11-SB 
11-sc 
Child 
Adult 
14.6 
16.4 
40-0 
1.1 
11.5 
34.8 
4.8 
7.7 
30-0 
1.3 
61.2 
44.7 
32-7 
34.0 
Not done 
53.5 
16.0 
80.9 
44.3 
13.2 
24.2 
38.9 
27.3 
64.9 
- 
11.7 
79.2 
11.4 
25.7 
85.5 
*The estimation was based on the hyaluronidase method of MATHEW and 
INOUYE (1961) as described in the text. 
Constituent analysis of the GAG fractions. Uronic acid analysis of the various 
GAG fractions by the carbazole method showed significant lowering in the colour 
yield in the absence of borate in the case of 111-SC indicating the presence of dermatan 
sulphate in this fraction only. 
The analytical data of the various GAG fractions of neonatal and adult brain are 
provided in Table 4. The hexosamine analysis shows that I-SA of the adult contains 
only glucosamine whereas in the neonate, there is a small amount of galactosamine 
also along with glucosamine. The ratios of galactosamine/glucosamine in I-SB and 
11-SB of the neonatal brain is higher than those of the corresponding fractions of the 
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TABLE %-ANALYTICAL DATA OF THE VARIOUS GAG FRACTIONS OF NEONATAL AND ADULT 
HUMAN BRAIN 
Age group and Galdctosamine/ 
Fraction Hexosamines* Glucosaminet 
Neonatal 
- 
I-SA 0.91 014 
I-SB 0.86 0.61 
IT-SB 0.89 1.3 
11-sc 0.93 Galactosamine 
only 
only 
Adult 
I-SA 0.98 Glucosamine 
I-SB 0.89 0.26 
11-SB 0.95 0.9 
11-sc 0.93 24.3 
III-sc 1.07 Galactosamine 
only 
Sulphate* N-Sulphate" 
Traces Not done 
0.42 Not done 
0-56 Not done 
0.98 Not done 
Not detect- 0.01 
table 
0.39 0.33 
0.72 017 
0.92 Traces 
0.96 Not done 
* Expressed as molar ratio of uronic acid. 
t Separation of glucosamine and galactosamine was carried out by the hexokinase 
method as described in the text. 
adult. Neonatal 11-SC contains only galactosamine, whereas the adult 11-SC contains 
a small amount of glucosamine also. 111-SC of the adult contains only galactosamine. 
The presence of more galactosamine in the various GAG fractions of the neonatal 
brain than in the corresponding fractions of the adult brain is of considerable interest. 
Total sulphate was estimated for the GAG fractions of foetal and child brain also. In 
general, I-SA contains only traces of sulphate and no age-dependent change in 
sulphate content could be observed. 
Further identijkation of hexosanzines. Further identification of the hexosamines 
has been carried out by paper chromatography. The results of these studies for the 
hexosamines of the adult brain GAG fractions showed the presence of some slow- 
moving faint spots in the case of 11-SB and 11-SC, which may be due to slight incom- 
plete hydrolysis. In general, under the conditions adopted for the present study, the 
hydrolysis of GAG for the release of hexosamines is almost complete for most of 
the GAG fractions and the results of chromatographic analysis agree with those 
obtained by the hexokinase reaction, followed by Dowex-1-acetate chromatography. 
Paper chromatographic studies of the hexosamines of the neonatal GAG fractions 
show that I-SA and 11-SC contain only glucosamine and galactosamine respectively, 
whereas both the amino sugars are present in I-SB and 11-SB. Although the presence 
of galactosamine has been observed in I-SA of the neonatal brain (Table 4), it could 
not be detected in the chromatogram, which may be due to this aminosugar being 
only a minor component. 
The results of N-sulphate analysis carried out for the various GAG fractions of the 
adult human brain show that I-SB and 11-SB definitely contain N-sulphate residues, 
whereas in 11-SC, it is almost negligible. However, I-SA, which does not have any 
sulphate at all, shows positive indole-HC1 reaction. Presence of certain compounds, 
like protein and peptides, are known to interfere with this method (LAGUNOFF and 
WARREN, 1962). The low value (0.01) of N-sulphate for I-SA, may be due to this 
reason. 
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Paper electrophoresis of the isolated GAG fractions. Paper electrophoresis shows 
single spots for the various GAG fractions of the neonatal brain (Fig. 1). I-SA has the 
same mobility as the standard hyaluronic acid and 11-SC, as chondroitin sulphates, 
while I-SB and 11-SB have identical mobility which is slightly lower than that of 
chondroitin sulphate but higher than that of hyaluronic acid 
In the electrophoregram of the various GAG fractions of the adult human brain 
(Fig. 2) I-SA shows a single spot having the same mobility as hyaluronic acid; I-SB 
also has a single spot with similar mobility as heparan sulphate. 11-SC and 111-SC 
give single spots with mobilities identical to that of chondroitin sulphates. But 11-SB 
resolves into two spots, the mobilities of which are nearer to that of heparan sulphate 
than those of other standards. The slower moving spot of 11-SB (Fig. 3) disappears 
on digestion with testicular hyaluronidase. 
+ 
Y Y Y " " I - " " " - . 
1 2  3 4 5 6  I 
FIG. 1.-Electrophoresis of the various GAG fractions of neonatal human brain. 
1 .  Standard hyaluronic acid; 2. I-SA; 3. I-SB; 4. 11-SB; 5. 11-SC and 6. Standard 
chondroitin sulphates. 
DISCUSSION 
In course of our studies on the isolation and characterization of GAG in the 
nervous tissues it was observed that the three different fractions obtained by the CPB 
procedure (SCHILLER et af . ,  1961) are not composed of single GAG. Further resolution 
of these fractions has been achieved by DEAE-Sephadex column chromatography 
(SCHMIDT, 1962). In the present investigation five different GAG fractions have been 
isolated from human brain. Rechromatography on DEAE-Sephadex columns and 
re-fractionation by the CPB procedure of these fractions gave rise to the same frac- 
tions, indicating that these are not artifacts of the isolation procedure. It is possible 
that some of these fractions are a mixture of GAG which cannot be further resolved 
into the individual components by the isolation procedure employed. Although it has 
not been possible to make a definite identification of each fraction, the analysis of 
these fractions suggests that they are different from one another. 
The results of chromatographic studies, paper electrophoresis and constituent 
analysis indicate I-SA to be a fairly pure hyaluronic acid fraction. However, the 
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1 1 2 3  4 5 6 7 0  
FIG. 2.-Electrophoresis of the various GAG fractions of adult human brain. 
1 .  I-SA; 2. Standard hyaluronic acid; 3. I-SB; 4. 11-SB; 5. Standard heparan 
sulphate; 6.  11-SC; 7. 111-SC and 8. Standard chondroitin sulphates. 
+ 
1 2 I 
FIG. 3.-Electrophoresis of 11-SB of adult human brain before and after 
hyaluronidase digestion. 1. Before digestion; 2. After digestion. 
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occurrence of a small amount of galactosamine and the absence of sulphate in this 
fraction of neonatal brain indicate the presence of chondroitin in this tissue. 
Since I-SB has got certain unusual features, as indicated by the results of the 
present study, no definite conclusion could be made regarding the nature of this 
fraction. Generally, it is found to contain more glucosamine than galactosamine and 
its sulphate content ranges from 30-50 per cent of the uronic acid and there is no 
indication for the presence of iduronic acid. Non-acetylated hexosamine determina- 
tion by the indole-HC1 method (LAGUNOFF and WARREN, 1962) indicates the presence 
of this sugar to the extent of 33 per cent of uronic acid in this fraction of adult brain. 
If this value represents N-sulphate residues only, it will account for 83 per cent of the 
total sulphate in this fraction. All these evidences suggest the similarity of this 
fraction to heparan sulphate, (with a low degree of sulphation). However, on the 
basis of the available information regarding the substrate specificity of testicular 
hyaluronidase, the digestion of this fraction to the extent of 83-93 per cent, is not 
consistent with its identification as heparan sulphate. On the other hand, the di- 
gestibility by hyaluronidase and the high glucosamine content (about 80 per cent of 
the total hexosamine in the case of adult brain) as well as its extraction by 0-4 M-NaCl 
from the GAG-CPB complex, suggest that a part of the glucosamine might be 
contributed by hyaluronic acid. But paper electrophoresis shows the presence of a 
single spot having higher mobility than hyaluronic acid. Moreover, preliminary in 
vitro sulphation studies with 6-day-old rat brain sulphotransferase (BALASUBRAMANIAN 
and BACHHAWAT, 1964) using this fraction as the acceptor showed that this fraction 
is a good acceptor of sulphate; and substances behaving like 11-SB and 11-SC, on 
CPB fractionation and DEAE-Sephadex chromatography, could be isolated as 
products of sulphation of I-SB. In the light of all this evidence, further structural 
investigation will be needed for a conclusive identification of this fraction. 
The identification of 11-SB also poses similar problems. 11-SB resembles I-SB in 
many respects but for the following differences: (i) a higher concentration of NaCl 
(i.e. 1.2 M) is needed to extract it from the GAG-CPB complex, (ii) it contains more 
galactosamine than I-SB, (iii) its degree of sulphation is higher than that of I-SB, 
(iv) it contains more hyaluronidase resistant material. In the case of adult human 
brain, 11-SB contains 30 per cent hyaluronidase-resistant material. Although this 
cannot account for the total amount of glucosamine present in this fraction (53 per 
cent of the total hexosamine), all the other evidences suggest that the undigestible 
material may be heparan sulphate. As in the case of I-SB, the characterization of 
the glucosamine containing, hyaluronidase sensitive material in this fraction needs to 
be further investigated before a definite conclusion is arrived at. However, the 
presence of chondroitin sulphates with low degree of sulphation can be inferred from 
the presence of galactosamine (47 per cent of the total hexosamine in the case of the 
adult) and the absence of iduronic acid. This observation has been further sub- 
stantiated by the isolation of radioactive XI-SC (which is identified as chondroitin 
sulphates) as a product of 11-SB sulphation in a preliminary in vitro sulphation study 
using [35S]PAPS and a sulphotransferase preparation obtained from 6-day-old rat 
brain (BALASUBRAMANIAN and BACHHAWAT, 1964). 
All the evidence suggests that 11-SC is primarily composed of chondroitin-6- 
sulphate and chondroitin-4-sulphate along with a negligible amount of hyaluronidase 
undigestible material. 
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In the earlier communication (SINGH and BACHHAWAT, 1965), Fraction I11 of 
sheep brain was tentatively identified as heparin, based on its behaviour in the CPB 
fractionation procedure and its anticoagulant activity of blood. But the limitation of 
such an identification without analysing the constituents was pointed out in the same 
communication. Further purification of this fraction and analysis of the constituents, 
viz. uronic acid, hexosamines and sulphate, show that this fraction is composed of 
dermatan sulphate only. However, it is not clear why dermatan sulphate is not 
extracted by 1.2 M-NaCI along with the chondroitin sulphates from the GAG-CPB 
complex. 
It is dear from the results obtained in this study that hyaluronic acid, chondroitin- 
6-sulphate, chondroitin-4-sulphate, dermatan sulphate and heparan sulphate are 
present in human brain, along with some low sulphated fractions, the nature of which 
is yet to be fully ascertained. The present findings which do not completely agree with 
any of the earlier reports (SZABO and ROBOZ-EINSTEIN, 1962; CLAUSEN and HANSEN, 
1963; MEYER ef al., 1959; MARGOLIS, 1967) indicate that a complete profile of GAG 
of brain has not been obtained by these workers. 
The relative amounts and types of GAG present in adult human brain from this 
study are: 
1. Hyaluronic acid comprises about 35 per cent of the total GAG in this tissue. 
2. 34 per cent of the 11-SC represents the next higher fraction in this tissue, 85 per 
cent of which is chondroitin-4-sulphate whereas only 13 per cent is chondroitin-6- 
sulphate. 
3. Dermatan sulphate accounts for about 5 per cent of the total GAG, 
4. 20 per cent of the total GAG is represented by the low sulphated fraction, 
11-SB, 30 per cent of which has been identified as heparan sulphate (probably with a 
lower degree of sulphatation) and another 47 per cent, as low sulphated chondroitin 
sulphate, the rest being the unidentified glucosamine containing, hyaluronidase 
sensitive sulphated compound. 
5. About 6 per cent of the total GAG is accounted for by the low sulphated 
fraction, I-SB, the exact nature of which still remains to be established. 
6. About 10 per cent of the total GAG remains to be characterized. 
The present findings of higher level of hyaluronic acid than those of chondroitin 
sulphate in the premyelination stages and the changes in the relative proportions of 
these compounds with the development and maturation of brain, are in good agree- 
ment with the earlier findings in the developing rat brain (SINGH and BACHHAWAT, 
1965). This further substantiates the earlier evidence from this laboratory (GUHA et 
al., 1960; BALASUBRAMANIAN and BACHHAWAT, 1964) supporting the postulation of 
BRANTE (1958) about the possible role of GAG in the process of myelination. Al- 
though the recent findings of MARCOLIS (1967) indicate that there is no GAG in the 
myelin sheath itself, the absence of GAG in the myelin itself does not completely rule 
out a possible role of GAG in the process of myelination and brain maturation. 
The results of chondroitin-6-sulphate estimation by the hyaluronidase method of 
MATHEW and INOUYE (1961) are difficult to interpret in the case of the unidentified 
fractions, viz. I-SB and 11-SB, as this method is based on slight structural differences 
between chondroitin-6-sulphate and chondroitin-4-sulphate. It also requires the 
absence of hyaluronidase sensitive GAG, like hyaluronic acid, which may give rise to 
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oligosaccharides containing terminal N-acetyl hexosamines responding to the Morgan- 
Elson reaction. The finding of 80.9 per cent of chondroitin-6-sulphate in the adult 
brain I-SB fraction which has only a small amount of galactosamine (20.6 per cent of 
the total hexosamine) indicates an inherent limitation of this method, when applied 
to GAG which is not properly characterized. In view of these considerations, the 
quantitative values of chondroitin-6-sulphate present in I-SB and 11-SB might be lower 
than indicated, and as such these results need to be interpreted with some reservation. 
However, in general the values of chondroitin-6-sulphate in 11-SC will be representa- 
tive of the true composition of this fraction. 
There is a significant change in the relative amounts of chondroitin-6-sulphate and 
chondroitin-4-sulphate (in 11-SC only) with age. In the neonatal period, chondroitin- 
6-sulphate represents 34 per cent of 11-SC, but in the child and the adult this percentage 
decreases to 16, and 13, respectively, with a concomitant rise in the percentage of 
chondroitin-4-sulphate. This finding is of great interest although its implication 
cannot be explained with the available data. 
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